Trial intelligence / Profile preview

Esomeprazole for Dysphagia Following Anterior Cervical Spine Surgery

NCT03488147Phase 2Withdrawn

Sponsor
Icahn School of Medicine at Mount Sinai
Start
Jul 2020
Primary completion
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of esomeprazole in dysphagia, sponsored by Icahn School of Medicine at Mount Sinai. Planned start Jul 2020; status: withdrawn.

02

Drugs

esomeprazole
03

Conditions

dysphagia

Beyond the preview

Go deeper on NCT03488147.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03488147.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call